Mass Spectrometry-Based Multivariate Proteomic Tests for Prediction of Outcomes on Immune Checkpoint Blockade Therapy: The Modern Analytical Approach.

Int J Mol Sci · 2020 · PMC7036840 · PMID 32012941

Europe PMC DOI

hedged sentence

0.1190

closest p · 2.4× alpha

0.1190

boldest claim

The sentences

did not reach statistical significancep = 0.119not close (p > 0.1)

Association of VeriStrat classification with PD-L1 status did not reach statistical significance in the interim analysis of the INSIGHT study ( p = 0.119) and continued to predict outcome when adjusted for PD-L1 status in multivariate analysis [ 49 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.